Global Coccidioidomycosis Drug Market Research Report 2024

Report ID: 1978235 | Published Date: Jan 2025 | No. of Page: 70 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Coccidioidomycosis Drug Market Overview
    1.1 Product Overview and Scope of Coccidioidomycosis Drug
    1.2 Coccidioidomycosis Drug Segment by Type
        1.2.1 Global Coccidioidomycosis Drug Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 VT-1161
        1.2.3 APX-001
        1.2.4 VT-1598
        1.2.5 Nikkomycin Z
        1.2.6 Others
    1.3 Coccidioidomycosis Drug Segment by Application
        1.3.1 Global Coccidioidomycosis Drug Sales Comparison by Application: (2022-2028)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Others
    1.4 Global Coccidioidomycosis Drug Market Size Estimates and Forecasts
        1.4.1 Global Coccidioidomycosis Drug Revenue 2017-2028
        1.4.2 Global Coccidioidomycosis Drug Sales 2017-2028
        1.4.3 Coccidioidomycosis Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Coccidioidomycosis Drug Market Competition by Manufacturers
    2.1 Global Coccidioidomycosis Drug Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Coccidioidomycosis Drug Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Coccidioidomycosis Drug Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Coccidioidomycosis Drug Manufacturing Sites, Area Served, Product Type
    2.5 Coccidioidomycosis Drug Market Competitive Situation and Trends
        2.5.1 Coccidioidomycosis Drug Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Coccidioidomycosis Drug Players Market Share by Revenue
        2.5.3 Global Coccidioidomycosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Coccidioidomycosis Drug Retrospective Market Scenario by Region
    3.1 Global Coccidioidomycosis Drug Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Coccidioidomycosis Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Coccidioidomycosis Drug Market Facts & Figures by Country
        3.3.1 North America Coccidioidomycosis Drug Sales by Country
        3.3.2 North America Coccidioidomycosis Drug Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Coccidioidomycosis Drug Market Facts & Figures by Country
        3.4.1 Europe Coccidioidomycosis Drug Sales by Country
        3.4.2 Europe Coccidioidomycosis Drug Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Coccidioidomycosis Drug Market Facts & Figures by Region
        3.5.1 Asia Pacific Coccidioidomycosis Drug Sales by Region
        3.5.2 Asia Pacific Coccidioidomycosis Drug Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Coccidioidomycosis Drug Market Facts & Figures by Country
        3.6.1 Latin America Coccidioidomycosis Drug Sales by Country
        3.6.2 Latin America Coccidioidomycosis Drug Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Coccidioidomycosis Drug Market Facts & Figures by Country
        3.7.1 Middle East and Africa Coccidioidomycosis Drug Sales by Country
        3.7.2 Middle East and Africa Coccidioidomycosis Drug Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Coccidioidomycosis Drug Historic Market Analysis by Type
    4.1 Global Coccidioidomycosis Drug Sales Market Share by Type (2017-2022)
    4.2 Global Coccidioidomycosis Drug Revenue Market Share by Type (2017-2022)
    4.3 Global Coccidioidomycosis Drug Price by Type (2017-2022)
5 Global Coccidioidomycosis Drug Historic Market Analysis by Application
    5.1 Global Coccidioidomycosis Drug Sales Market Share by Application (2017-2022)
    5.2 Global Coccidioidomycosis Drug Revenue Market Share by Application (2017-2022)
    5.3 Global Coccidioidomycosis Drug Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Amplyx Pharmaceuticals Inc
        6.1.1 Amplyx Pharmaceuticals Inc Corporation Information
        6.1.2 Amplyx Pharmaceuticals Inc Description and Business Overview
        6.1.3 Amplyx Pharmaceuticals Inc Coccidioidomycosis Drug Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Amplyx Pharmaceuticals Inc Coccidioidomycosis Drug Product Portfolio
        6.1.5 Amplyx Pharmaceuticals Inc Recent Developments/Updates
    6.2 Valley Fever Solutions Inc
        6.2.1 Valley Fever Solutions Inc Corporation Information
        6.2.2 Valley Fever Solutions Inc Description and Business Overview
        6.2.3 Valley Fever Solutions Inc Coccidioidomycosis Drug Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Valley Fever Solutions Inc Coccidioidomycosis Drug Product Portfolio
        6.2.5 Valley Fever Solutions Inc Recent Developments/Updates
    6.3 Viamet Pharmaceuticals Inc
        6.3.1 Viamet Pharmaceuticals Inc Corporation Information
        6.3.2 Viamet Pharmaceuticals Inc Description and Business Overview
        6.3.3 Viamet Pharmaceuticals Inc Coccidioidomycosis Drug Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Viamet Pharmaceuticals Inc Coccidioidomycosis Drug Product Portfolio
        6.3.5 Viamet Pharmaceuticals Inc Recent Developments/Updates
7 Coccidioidomycosis Drug Manufacturing Cost Analysis
    7.1 Coccidioidomycosis Drug Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Coccidioidomycosis Drug
    7.4 Coccidioidomycosis Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Coccidioidomycosis Drug Distributors List
    8.3 Coccidioidomycosis Drug Customers
9 Coccidioidomycosis Drug Market Dynamics
    9.1 Coccidioidomycosis Drug Industry Trends
    9.2 Coccidioidomycosis Drug Market Drivers
    9.3 Coccidioidomycosis Drug Market Challenges
    9.4 Coccidioidomycosis Drug Market Restraints
10 Global Market Forecast
    10.1 Coccidioidomycosis Drug Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Coccidioidomycosis Drug by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Coccidioidomycosis Drug by Type (2023-2028)
    10.2 Coccidioidomycosis Drug Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Coccidioidomycosis Drug by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Coccidioidomycosis Drug by Application (2023-2028)
    10.3 Coccidioidomycosis Drug Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Coccidioidomycosis Drug by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Coccidioidomycosis Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Coccidioidomycosis Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
    Table 2. Global Coccidioidomycosis Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
    Table 3. Global Coccidioidomycosis Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Coccidioidomycosis Drug Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Coccidioidomycosis Drug Sales (K Pcs) of Key Manufacturers (2017-2022)
    Table 6. Global Coccidioidomycosis Drug Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Coccidioidomycosis Drug Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Coccidioidomycosis Drug Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Coccidioidomycosis Drug Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Coccidioidomycosis Drug Manufacturing Sites and Area Served
    Table 11. Manufacturers Coccidioidomycosis Drug Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Coccidioidomycosis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Coccidioidomycosis Drug as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Coccidioidomycosis Drug Sales by Region (2017-2022) & (K Pcs)
    Table 16. Global Coccidioidomycosis Drug Sales Market Share by Region (2017-2022)
    Table 17. Global Coccidioidomycosis Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Coccidioidomycosis Drug Revenue Market Share by Region (2017-2022)
    Table 19. North America Coccidioidomycosis Drug Sales by Country (2017-2022) & (K Pcs)
    Table 20. North America Coccidioidomycosis Drug Sales Market Share by Country (2017-2022)
    Table 21. North America Coccidioidomycosis Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Coccidioidomycosis Drug Revenue Market Share by Country (2017-2022)
    Table 23. Europe Coccidioidomycosis Drug Sales by Country (2017-2022) & (K Pcs)
    Table 24. Europe Coccidioidomycosis Drug Sales Market Share by Country (2017-2022)
    Table 25. Europe Coccidioidomycosis Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Coccidioidomycosis Drug Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Coccidioidomycosis Drug Sales by Region (2017-2022) & (K Pcs)
    Table 28. Asia Pacific Coccidioidomycosis Drug Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Coccidioidomycosis Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Coccidioidomycosis Drug Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Coccidioidomycosis Drug Sales by Country (2017-2022) & (K Pcs)
    Table 32. Latin America Coccidioidomycosis Drug Sales Market Share by Country (2017-2022)
    Table 33. Latin America Coccidioidomycosis Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Coccidioidomycosis Drug Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Coccidioidomycosis Drug Sales by Country (2017-2022) & (K Pcs)
    Table 36. Middle East and Africa Coccidioidomycosis Drug Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Coccidioidomycosis Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Coccidioidomycosis Drug Revenue Market Share by Country (2017-2022)
    Table 39. Global Coccidioidomycosis Drug Sales by Type (2017-2022) & (K Pcs)
    Table 40. Global Coccidioidomycosis Drug Sales Market Share by Type (2017-2022)
    Table 41. Global Coccidioidomycosis Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Coccidioidomycosis Drug Revenue Share by Type (2017-2022)
    Table 43. Global Coccidioidomycosis Drug Price by Type (2017-2022) & (USD/Pcs)
    Table 44. Global Coccidioidomycosis Drug Sales (K Pcs) by Application (2017-2022)
    Table 45. Global Coccidioidomycosis Drug Sales Market Share by Application (2017-2022)
    Table 46. Global Coccidioidomycosis Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Coccidioidomycosis Drug Revenue Share by Application (2017-2022)
    Table 48. Global Coccidioidomycosis Drug Price by Application (2017-2022) & (USD/Pcs)
    Table 49. Amplyx Pharmaceuticals Inc Corporation Information
    Table 50. Amplyx Pharmaceuticals Inc Description and Business Overview
    Table 51. Amplyx Pharmaceuticals Inc Coccidioidomycosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 52. Amplyx Pharmaceuticals Inc Coccidioidomycosis Drug Product
    Table 53. Amplyx Pharmaceuticals Inc Recent Developments/Updates
    Table 54. Valley Fever Solutions Inc Corporation Information
    Table 55. Valley Fever Solutions Inc Description and Business Overview
    Table 56. Valley Fever Solutions Inc Coccidioidomycosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 57. Valley Fever Solutions Inc Coccidioidomycosis Drug Product
    Table 58. Valley Fever Solutions Inc Recent Developments/Updates
    Table 59. Viamet Pharmaceuticals Inc Corporation Information
    Table 60. Viamet Pharmaceuticals Inc Description and Business Overview
    Table 61. Viamet Pharmaceuticals Inc Coccidioidomycosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 62. Viamet Pharmaceuticals Inc Coccidioidomycosis Drug Product
    Table 63. Viamet Pharmaceuticals Inc Recent Developments/Updates
    Table 64. Production Base and Market Concentration Rate of Raw Material
    Table 65. Key Suppliers of Raw Materials
    Table 66. Coccidioidomycosis Drug Distributors List
    Table 67. Coccidioidomycosis Drug Customers List
    Table 68. Coccidioidomycosis Drug Market Trends
    Table 69. Coccidioidomycosis Drug Market Drivers
    Table 70. Coccidioidomycosis Drug Market Challenges
    Table 71. Coccidioidomycosis Drug Market Restraints
    Table 72. Global Coccidioidomycosis Drug Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 73. Global Coccidioidomycosis Drug Sales Market Share Forecast by Type (2023-2028)
    Table 74. Global Coccidioidomycosis Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 75. Global Coccidioidomycosis Drug Revenue Market Share Forecast by Type (2023-2028)
    Table 76. Global Coccidioidomycosis Drug Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 77. Global Coccidioidomycosis Drug Sales Market Share Forecast by Application (2023-2028)
    Table 78. Global Coccidioidomycosis Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 79. Global Coccidioidomycosis Drug Revenue Market Share Forecast by Application (2023-2028)
    Table 80. Global Coccidioidomycosis Drug Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 81. Global Coccidioidomycosis Drug Sales Market Share Forecast by Region (2023-2028)
    Table 82. Global Coccidioidomycosis Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 83. Global Coccidioidomycosis Drug Revenue Market Share Forecast by Region (2023-2028)
    Table 84. Research Programs/Design for This Report
    Table 85. Key Data Information from Secondary Sources
    Table 86. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Coccidioidomycosis Drug
    Figure 2. Global Coccidioidomycosis Drug Market Share by Type in 2021 & 2028
    Figure 3. VT-1161 Product Picture
    Figure 4. APX-001 Product Picture
    Figure 5. VT-1598 Product Picture
    Figure 6. Nikkomycin Z Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Coccidioidomycosis Drug Market Share by Application in 2021 & 2028
    Figure 9. Clinic
    Figure 10. Hospital
    Figure 11. Others
    Figure 12. Global Coccidioidomycosis Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Coccidioidomycosis Drug Market Size (2017-2028) & (US$ Million)
    Figure 14. Global Coccidioidomycosis Drug Sales (2017-2028) & (K Pcs)
    Figure 15. Coccidioidomycosis Drug Sales Share by Manufacturers in 2021
    Figure 16. Global Coccidioidomycosis Drug Revenue Share by Manufacturers in 2021
    Figure 17. The Global 5 and 10 Largest Coccidioidomycosis Drug Players: Market Share by Revenue in 2021
    Figure 18. Coccidioidomycosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 19. Global Coccidioidomycosis Drug Sales Market Share by Region (2017-2022)
    Figure 20. Global Coccidioidomycosis Drug Sales Market Share by Region in 2021
    Figure 21. Global Coccidioidomycosis Drug Revenue Market Share by Region (2017-2022)
    Figure 22. Global Coccidioidomycosis Drug Revenue Market Share by Region in 2021
    Figure 23. U.S. Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Canada Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Germany Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. France Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. U.K. Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Italy Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Russia Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. China Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Japan Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. South Korea Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. India Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Australia Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Taiwan Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Indonesia Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Thailand Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Malaysia Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Philippines Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Vietnam Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Mexico Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Brazil Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Argentina Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Turkey Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Saudi Arabia Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. UAE Coccidioidomycosis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Sales Market Share of Coccidioidomycosis Drug by Type (2017-2022)
    Figure 48. Manufacturing Cost Structure of Coccidioidomycosis Drug
    Figure 49. Manufacturing Process Analysis of Coccidioidomycosis Drug
    Figure 50. Coccidioidomycosis Drug Industrial Chain Analysis
    Figure 51. Channels of Distribution
    Figure 52. Distributors Profiles
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amplyx Pharmaceuticals Inc
Valley Fever Solutions Inc
Viamet Pharmaceuticals Inc
Frequently Asked Questions
Coccidioidomycosis Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Coccidioidomycosis Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Coccidioidomycosis Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports